Acomplia

Acomplia (Rimonabant), also known to some as Zimulti, is the latest of three prescription slimming pills available for the treatment of obesity throughout the UK. It is a new class of medication which works on both the central nervous system and encannbinoid system, which regulates body weight and metabolism allowing patients to both loose weight whilst maintaining a high metabolic rate. Manufactured by Sanofi-Aventis, this one a day solution to a modern day problem has taken the world by storm with it fast becoming the medication of choice for those who suffer from obesity as well as attributing risk factors such as diabetes and high cholesterol.